Pilates is beneficial adjunctive therapy in heart failure

Pilates is beneficial adjunctive therapy in heart failure
Pilates exercises may be a beneficial adjunctive treatment for patients with heart failure, offering functional capacity improvements, according to a study published in the December issue of Cardiovascular Therapeutics.

(HealthDay)—Pilates exercises may be a beneficial adjunctive treatment for patients with heart failure, offering functional capacity improvements, according to a study published in the December issue of Cardiovascular Therapeutics.

To examine the efficacy of Pilates in patients with , Guilherme Veiga Guimarães, M.D., of the Universidade de São Paulo in Brazil, and colleagues conducted a study involving 16 patients with New York Heart Association class I or II heart failure who were randomly assigned to 30 minutes of aerobic exercise followed by 20 minutes of either mat Pilates training or a conventional for 16 weeks.

At 16 weeks, the researchers found that patients in both groups showed a significant increase in exercise time, with a larger increase for the Pilates group (11.9 ± 2.5 to 17.8 ± 4 minutes and 11.7 ± 3.9 to 14.2 ± 4 minutes, respectively). Only the Pilates training exhibited significant increases from baseline in ventilation, peak (VO2), and O2 pulse. Compared with the conventional group, peak VO2 was significantly improved in the Pilates group.

"The results of this study demonstrate the feasibility of a combined aerobic training and mat Pilates method by its safe and functional capacity improvements in ," the authors write.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Exercise training improves cardiac parameters in lupus

Apr 05, 2012

(HealthDay) -- For inactive patients with systemic lupus erythematosus (SLE), a three-month exercise training program is associated with improved chronotropic reserve and heart rate recovery, according to ...

Recommended for you

Vitamin K antagonist plus clopidogrel feasible for PCI

Sep 19, 2014

(HealthDay)—Vitamin K antagonists (VKA) combined with clopidogrel may be a better alternative to triple anticoagulant therapy in patients on long-term VKA undergoing percutaneous coronary intervention (PCI) ...

How pneumonia bacteria can compromise heart health

Sep 19, 2014

Bacterial pneumonia in adults carries an elevated risk for adverse cardiac events (such as heart failure, arrhythmias, and heart attacks) that contribute substantially to mortality—but how the heart is ...

User comments